Last update 05 Mar 2026

Ezetimibe/Fimasartan Potassium Trihydrate/Atorvastatin Calcium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Kanarbzet, 카나브젯정
Target
AT1R x HMGCR x NPC1L1
Action
antagonists, inhibitors
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), NPC1L1 inhibitors(Niemann-Pick C1-like protein 1 inhibitors)
Therapeutic Areas
Cardiovascular DiseasesCongenital DisordersEndocrinology and Metabolic Disease+ [1]
Active Indication
Essential HypertensionHomozygous familial hypercholesterolemiaPrimary hypercholesterolemia
Inactive Indication-
Originator Organization
Boryung Corp.Boryung Corp.
Active Organization
Boryung Corp.Boryung Corp.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
South Korea (27 Feb 2026),
Essential HypertensionHomozygous familial hypercholesterolemiaPrimary hypercholesterolemia
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC27H31N7OS
InChIKeyAMEROGPZOLAFBN-UHFFFAOYSA-N
CAS Registry247257-48-3
View All Structures (5)

Related

100 Clinical Results associated with Ezetimibe/Fimasartan Potassium Trihydrate/Atorvastatin Calcium
Login to view more data
100 Translational Medicine associated with Ezetimibe/Fimasartan Potassium Trihydrate/Atorvastatin Calcium
Login to view more data
100 Patents (Medical) associated with Ezetimibe/Fimasartan Potassium Trihydrate/Atorvastatin Calcium
Login to view more data
100 Deals associated with Ezetimibe/Fimasartan Potassium Trihydrate/Atorvastatin Calcium
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Essential Hypertension
South Korea
Boryung Corp.Boryung Corp.
27 Feb 2026
Homozygous familial hypercholesterolemia
South Korea
Boryung Corp.Boryung Corp.
27 Feb 2026
Primary hypercholesterolemia
South Korea
Boryung Corp.Boryung Corp.
27 Feb 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free